Chemistry:Linvemastat
From HandWiki
Linvemastat is an investigational new drug that is being evaluated by Foresee Pharmaceuticals for the treatment of Asthma.[1] It is a matrix metalloproteinase 12 inhibitor.[1][2]
References
- ↑ 1.0 1.1 "Linvemastat". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800074199.
- ↑ "An overview of matrix metalloproteinase-12 in multiple disease conditions, potential selective inhibitors, and drug designing strategies". European Journal of Medicinal Chemistry 283. February 2025. doi:10.1016/j.ejmech.2024.117154. PMID 39709794.
 |  |
